Jozwiak M, Bauer M, Kamysz W, Kleczkowska P
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40005999
PMC: 11859134.
DOI: 10.3390/ph18020185.
Scholefield M, Church S, Cooper G
Metallomics. 2025; 17(3).
PMID: 39933566
PMC: 11895508.
DOI: 10.1093/mtomcs/mfaf006.
Huang Y, Wang X, Li W, Yue F, Wang M, Zhou F
Int J Nanomedicine. 2024; 19:10401-10414.
PMID: 39430307
PMC: 11490209.
DOI: 10.2147/IJN.S479670.
Samuel Olajide T, Oyerinde T, Omotosho O, Okeowo O, Olajide O, Ijomone O
Neuroprotection. 2024; 2(3):182-195.
PMID: 39364217
PMC: 11449118.
DOI: 10.1002/nep3.56.
Negida A, Hassan N, Aboeldahab H, Zain Y, Negida Y, Cadri S
CNS Neurosci Ther. 2024; 30(2):e14607.
PMID: 38334258
PMC: 10853946.
DOI: 10.1111/cns.14607.
The mechanism of ferroptosis and its related diseases.
Feng S, Tang D, Wang Y, Li X, Bao H, Tang C
Mol Biomed. 2023; 4(1):33.
PMID: 37840106
PMC: 10577123.
DOI: 10.1186/s43556-023-00142-2.
Alzheimer's Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress.
Valverde-Salazar V, Ruiz-Gabarre D, Garcia-Escudero V
Antioxidants (Basel). 2023; 12(7).
PMID: 37507998
PMC: 10376369.
DOI: 10.3390/antiox12071460.
Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes.
Wang Y, Wu S, Li Q, Sun H, Wang H
Adv Sci (Weinh). 2023; 10(24):e2300325.
PMID: 37341302
PMC: 10460905.
DOI: 10.1002/advs.202300325.
Cortical iron accumulation in MAPT- and C9orf 72-associated frontotemporal lobar degeneration.
Giannini L, Bulk M, Kenkhuis B, Rajicic A, Melhem S, Hegeman-Kleinn I
Brain Pathol. 2023; 33(4):e13158.
PMID: 36974379
PMC: 10307524.
DOI: 10.1111/bpa.13158.
Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders.
Li J, Jia B, Cheng Y, Song Y, Li Q, Luo C
Oxid Med Cell Longev. 2022; 2022:3999083.
PMID: 35910843
PMC: 9337979.
DOI: 10.1155/2022/3999083.
Therapeutic Strategies and Metal-Induced Oxidative Stress: Application of Synchrotron Radiation Microbeam to Amyotrophic Lateral Sclerosis in the Kii Peninsula of Japan.
Yoshida S
Front Neurol. 2022; 13:884439.
PMID: 35837234
PMC: 9273737.
DOI: 10.3389/fneur.2022.884439.
A brief history of brain iron accumulation in Parkinson disease and related disorders.
Foley P, Hare D, Double K
J Neural Transm (Vienna). 2022; 129(5-6):505-520.
PMID: 35534717
PMC: 9188502.
DOI: 10.1007/s00702-022-02505-5.
Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia.
Kenkhuis B, van Eekeren M, Parfitt D, Ariyurek Y, Banerjee P, Priller J
Stem Cell Reports. 2022; 17(6):1351-1365.
PMID: 35523178
PMC: 9213827.
DOI: 10.1016/j.stemcr.2022.04.006.
Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease.
Boag M, Roberts A, Uversky V, Ma L, Richardson D, Pountney D
Int J Mol Sci. 2022; 23(4).
PMID: 35216492
PMC: 8878351.
DOI: 10.3390/ijms23042378.
Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
Raha A, Biswas A, Henderson J, Chakraborty S, Holland A, Friedland R
Int J Mol Sci. 2022; 23(3).
PMID: 35162984
PMC: 8834792.
DOI: 10.3390/ijms23031060.
Low plasma serotonin linked to higher nigral iron in Parkinson's disease.
Jellen L, Lewis M, Du G, Wang X, Escobar Galvis M, Krzyzanowski S
Sci Rep. 2021; 11(1):24384.
PMID: 34934078
PMC: 8692322.
DOI: 10.1038/s41598-021-03700-2.
Mitochondrial iron metabolism and neurodegenerative diseases.
Cheng R, Dhorajia V, Kim J, Kim Y
Neurotoxicology. 2021; 88:88-101.
PMID: 34748789
PMC: 8748425.
DOI: 10.1016/j.neuro.2021.11.003.
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.
Riederer P, Monoranu C, Strobel S, Iordache T, Sian-Hulsmann J
J Neural Transm (Vienna). 2021; 128(10):1577-1598.
PMID: 34636961
PMC: 8507512.
DOI: 10.1007/s00702-021-02414-z.
Role of Oxidative Damage in Alzheimer's Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery.
Buccellato F, DAnca M, Fenoglio C, Scarpini E, Galimberti D
Antioxidants (Basel). 2021; 10(9).
PMID: 34572985
PMC: 8471953.
DOI: 10.3390/antiox10091353.
Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging.
Korzhevskii D, Kirik O, Guselnikova V, Tsyba D, Fedorova E, Grigorev I
Eur J Histochem. 2021; 65(s1).
PMID: 34468106
PMC: 8419629.
DOI: 10.4081/ejh.2021.3283.